# Immuno-positron Emission Tomography Study of 89Zr-S095012 in Patients With Advanced Solid Tumours

> **NCT05638334** · PHASE1 · TERMINATED · sponsor: **Institut de Recherches Internationales Servier** · enrollment: 3 (actual)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** 89Zr-S095012 tracer and S095012 will be administered via an IV infusion

## Key facts

- **NCT ID:** NCT05638334
- **Lead sponsor:** Institut de Recherches Internationales Servier
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-11-21
- **Primary completion:** 2024-06-14
- **Final completion:** 2024-06-14
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05638334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05638334, "Immuno-positron Emission Tomography Study of 89Zr-S095012 in Patients With Advanced Solid Tumours". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05638334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*